Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis
A retrospective analysis of 70 patients with triple-negative or hormone-resistant advanced breast carcinoma who had not previously received chemotherapy was carried out. Patients received oral vinorelbine 60 mg/m2 on day 1 and 8, plus capecitabine 1000 mg/m2 bid for 14 consecutive days every 3 weeks...
שמור ב:
| Principais autores: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2021-12-01
|
| סדרה: | Future Science OA |
| נושאים: | |
| גישה מקוונת: | https://www.future-science.com/doi/10.2144/fsoa-2020-0095 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|